Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia
Conditions
- Schizophrenia
- Central Nervous System Diseases
- Cognition
Interventions
- DRUG: EVP-6124
- DRUG: Placebo
- DRUG: EVP-6124
Sponsor
FORUM Pharmaceuticals Inc
Collaborators